Literature DB >> 23821568

Comparison of the quantitative performance of a Q-Exactive high-resolution mass spectrometer with that of a triple quadrupole tandem mass spectrometer for the analysis of illicit drugs in wastewater.

Ganna Fedorova1, Tomas Randak, Richard H Lindberg, Roman Grabic.   

Abstract

RATIONALE: Analysis of drugs in wastewater is gaining more interest, as new approaches to estimate drug consumption from the amount of drug residues in wastewater have been proposed. The aim of this study was to compare the quantitative performance of high-resolution mass spectrometry with that of triple quadrupole mass spectrometry.
METHODS: A Q-Exactive mass spectrometer was operated in full scan (HRFS) (70 000 FWHM) and product scan (HRPS) (17 500 FWHM) modes. The first and third quadrupoles of the QqQ MS/MS instrument were operated at 0.7 FWHM. A mass-extracted window of 5 ppm around the theoretical m/z of each analyte was used to construct chromatograms. An HESI-II ion source was used for the ionization of target compounds. In-line-SPE-LC configuration was used for the extraction and separation of target analytes.
RESULTS: All three methods showed good linearity and repeatability. High-resolution detection of product ions exhibited better sensitivity and selectivity for some compounds. For most of the tested compounds, LOQs ranged from 0.46 to 20 ng L(-1) . Good agreement between measured and nominal concentrations was observed for most of the compounds at different levels of fortification. Both MS/MS methods showed good selectivity, while HRFS gave some false positive results.
CONCLUSIONS: The Q-Exactive mass spectrometer proved to be suitable for trace detection and quantification of most of the tested drugs in wastewater, with performance comparable to that of the commonly used MS/MS triple quadrupole, but with better selectivity.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23821568     DOI: 10.1002/rcm.6628

Source DB:  PubMed          Journal:  Rapid Commun Mass Spectrom        ISSN: 0951-4198            Impact factor:   2.419


  17 in total

1.  Survey of the occurrence of pharmaceuticals in Spanish finished drinking waters.

Authors:  M Rosa Boleda; Elida Alechaga; Encarnación Moyano; M Teresa Galceran; Francesc Ventura
Journal:  Environ Sci Pollut Res Int       Date:  2014-04-24       Impact factor: 4.223

2.  Proposed Confidence Scale and ID Score in the Identification of Known-Unknown Compounds Using High Resolution MS Data.

Authors:  Bertrand Rochat
Journal:  J Am Soc Mass Spectrom       Date:  2017-01-23       Impact factor: 3.109

3.  Occurrence of illicit drugs and selected pharmaceuticals in Slovak municipal wastewater.

Authors:  Igor Bodík; Tomáš Mackuľak; Milota Fáberová; Lucia Ivanová
Journal:  Environ Sci Pollut Res Int       Date:  2016-08-17       Impact factor: 4.223

4.  The influence of selected pharmaceuticals on biogas production from laboratory and real anaerobic sludge.

Authors:  Milota Fáberová; Lucia Ivanová; Petra Szabová; Magdalena Štolcová; Igor Bodík
Journal:  Environ Sci Pollut Res Int       Date:  2019-09-05       Impact factor: 4.223

5.  Hospital wastewaters treatment: Fenton reaction vs. BDDE vs. ferrate(VI).

Authors:  Tomáš Mackuľak; Roman Grabic; Viera Špalková; Noemi Belišová; Andrea Škulcová; Ondřej Slavík; Pavel Horký; Miroslav Gál; Jan Filip; Ján Híveš; Marian Vojs; Andrea Vojs Staňová; Alžbeta Medveďová; Marián Marton; Lucia Birošová
Journal:  Environ Sci Pollut Res Int       Date:  2019-09-05       Impact factor: 4.223

6.  National monitoring of nicotine use in Czech and Slovak Republic based on wastewater analysis.

Authors:  Tomáš Mackuľak; Lucia Birošová; Roman Grabic; Jaroslav Škubák; Igor Bodík
Journal:  Environ Sci Pollut Res Int       Date:  2015-05-09       Impact factor: 4.223

7.  Wastewater analysis: the mean of the monitoring of frequently prescribed pharmaceuticals in Slovakia.

Authors:  Tomáš Mackuľak; Lucia Birošová; Miroslav Gál; Igor Bodík; Roman Grabic; Jozef Ryba; Jaroslav Škubák
Journal:  Environ Monit Assess       Date:  2015-12-09       Impact factor: 2.513

8.  Nano-LC-MS/MS for Quantification of Lyso-Gb3 and Its Analogues Reveals a Useful Biomarker for Fabry Disease.

Authors:  Hideaki Sueoka; Junji Ichihara; Takahiro Tsukimura; Tadayasu Togawa; Hitoshi Sakuraba
Journal:  PLoS One       Date:  2015-05-12       Impact factor: 3.240

9.  Development and quantitative evaluation of a high-resolution metabolomics technology.

Authors:  Xiaojing Liu; Zheng Ser; Jason W Locasale
Journal:  Anal Chem       Date:  2014-01-28       Impact factor: 6.986

10.  Large-scale label-free comparative proteomics analysis of polo-like kinase 1 inhibition via the small-molecule inhibitor BI 6727 (Volasertib) in BRAF(V600E) mutant melanoma cells.

Authors:  Brian D Cholewa; Molly C Pellitteri-Hahn; Cameron O Scarlett; Nihal Ahmad
Journal:  J Proteome Res       Date:  2014-06-09       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.